Physician profile
Roxanne E Pero
NPI 1508069790
$1,120.44
in general payments reported to CMS, 2019-2025
25 companies · $14.05 in 2025
The $14.05 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $250 · 2021: $429 · 2023: $42.60 · 2024: $14.20 · 2025: $14.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.33 | 2019-2021 | |
| Avanos Medical | $91.72 | 2021 | |
| Therapeuticsmd, INC. | $68.74 | 2019-2021 | |
| Smith+Nephew, INC. | $67.59 | 2020-2021 | |
| Pfizer INC. | $55.26 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $50.50 | 2019 | |
| Exeltis, USA INC. | $46.32 | 2021 | |
| Daiichi Sankyo INC. | $38.17 | 2019-2023 | Enhertu |
| Merck Sharp & Dohme LLC | $36.25 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.25 | 2024-2025 | Xifaxan, Trulance |
| Amag Pharmaceuticals, INC. | $26.40 | 2019 | |
| Biom'Up France Sas | $24.13 | 2021 | |
| Agile Therapeutics, INC. | $23.91 | 2021 | |
| Mayne Pharma Commercial LLC | $22.44 | 2021 | |
| Acella Pharmaceuticals, LLC | $21.72 | 2023 | NP Thyroid 60 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $18.31 | 2019 | |
| Kci USA, INC. | $17.67 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2020 | |
| Kedrion Biopharma INC. | $15.91 | 2019 | |
| Duchesnay USA Incorporated | $14.48 | 2019 | |
| Organon LLC | $13.99 | 2021 | |
| Pylant Medical | $13.79 | 2019 | |
| Lupin INC. | $13.26 | 2019 | |
| Allergan, INC. | $10.84 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxanne Pero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.